Tech Company Financing Transactions

Tisbury Pharmaceuticals Funding Round

On 6/17/2017, Tisbury Pharmaceuticals raised $32 million in Series A funding from Clarus, Healthcap Venture Capital and OrbiMed.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

100 Cummings Center 412G
Beverly, MA 01915
USA

Phone

Undisclosed

Website

www.tisburypharmaceuticals.com

Email Address

Not Recorded

Overview

Tisbury Pharmaceuticals, Inc. discovers, develops, and commercializes therapy to treat primary open angle glaucoma. The company's clinical candidate, R-801, accelerates flow via the trabecular meshwork via redox catalysis and K+-ATP (channel activation). The company was incorporated in 2017.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Gary Sternberg

        

Browse more venture capital transactions:

Prev: 6/17/2017: Guazi.com venture capital transaction
Next: 6/19/2017: BlueLine Grid venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary